342 related articles for article (PubMed ID: 34384744)
41. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
[TBL] [Abstract][Full Text] [Related]
42. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
Rieux-Laucat F; Magérus-Chatinet A; Neven B
J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
[TBL] [Abstract][Full Text] [Related]
43. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
[TBL] [Abstract][Full Text] [Related]
44. The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial.
Krausz M; Uhlmann A; Rump IC; Ihorst G; Goldacker S; Sogkas G; Posadas-Cantera S; Schmidt R; Feißt M; Alsina L; Dybedal I; Recher M; Warnatz K; Grimbacher B
Contemp Clin Trials Commun; 2022 Dec; 30():101008. PubMed ID: 36262801
[TBL] [Abstract][Full Text] [Related]
45. Unusual Late-onset Enteropathy in a Patient With Lipopolysaccharide-responsive Beige-like Anchor Protein Deficiency.
Maggiore R; Grossi A; Fioredda F; Palmisani E; Terranova P; Cappelli E; Lanza T; Pierri F; Guardo D; Calvillo M; Micalizzi C; Beccaria A; Coccia MC; Arrigo S; Dufour C; Ceccherini I; Miano M
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e768-e771. PubMed ID: 31876783
[TBL] [Abstract][Full Text] [Related]
46. Key diagnostic markers for autoimmune lymphoproliferative syndrome with molecular genetic diagnosis.
Molnár E; Radwan N; Kovács G; Andrikovics H; Henriquez F; Zarafov A; Hayman M; Linzner D; Thrasher AJ; Buckland M; Burns SO; Gilmour KC
Blood; 2020 Oct; 136(17):1933-1945. PubMed ID: 32599613
[TBL] [Abstract][Full Text] [Related]
47. Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance.
Hsu AP; Dowdell KC; Davis J; Niemela JE; Anderson SM; Shaw PA; Rao VK; Puck JM
Genet Med; 2012 Jan; 14(1):81-9. PubMed ID: 22237435
[TBL] [Abstract][Full Text] [Related]
48. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
[TBL] [Abstract][Full Text] [Related]
49. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
Front Immunol; 2018; 9():2400. PubMed ID: 30386345
[TBL] [Abstract][Full Text] [Related]
50. Patients with "ALPS-like phenotype" diagnosed with immune dysregulation due to LRBA deficiency.
Fernández KS; Antony R; Kumar A
Pediatr Blood Cancer; 2019 Mar; 66(3):e27558. PubMed ID: 30479033
[No Abstract] [Full Text] [Related]
51. Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders.
Failing C; Blase JR; Walkovich K
Rheum Dis Clin North Am; 2023 Nov; 49(4):841-860. PubMed ID: 37821199
[TBL] [Abstract][Full Text] [Related]
52. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
Consonni F; Gambineri E; Favre C
Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
[TBL] [Abstract][Full Text] [Related]
53. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
[TBL] [Abstract][Full Text] [Related]
54. LRBA deficiency: a rare cause of type 1 diabetes, colitis, and severe immunodeficiency.
Kardelen AD; Kara M; Güller D; Ozturan EK; Abalı ZY; Ceylaner S; Kıykım A; Cantez S; Torun SH; Poyrazoglu S; Bas F; Darendelıler F
Hormones (Athens); 2021 Jun; 20(2):389-394. PubMed ID: 33155142
[TBL] [Abstract][Full Text] [Related]
55. Interstitial Lung Disease in an Adolescent Girl with Lipopolysaccharide-Responsive Beige-Like Anchor Deficiency.
Tuğcu GD; Eryılmaz Polat S; Metin A; Orhan D; Cinel G
Pediatr Allergy Immunol Pulmonol; 2022 Sep; 35(3):133-138. PubMed ID: 36121783
[No Abstract] [Full Text] [Related]
56. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
Kuehn HS; Caminha I; Niemela JE; Rao VK; Davis J; Fleisher TA; Oliveira JB
J Immunol; 2011 May; 186(10):6035-43. PubMed ID: 21490157
[TBL] [Abstract][Full Text] [Related]
57. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
[TBL] [Abstract][Full Text] [Related]
58. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
[TBL] [Abstract][Full Text] [Related]
59. The genetic landscape of the FAS pathway deficiencies.
Magerus A; Bercher-Brayer C; Rieux-Laucat F
Biomed J; 2021 Aug; 44(4):388-399. PubMed ID: 34171534
[TBL] [Abstract][Full Text] [Related]
60. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
